Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic method for Parecoxib Sodium Impurity I ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel one-pot reduction method for 4-bromoindole offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110668958A reveals a high-purity synthesis route for (R)-3-aminobutanol, a key Dolutegravir intermediate, offering significant cost and supply chain advantages.
Patent CN119118862B reveals one-step agomelatine synthesis reducing complexity. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN117886789A reveals efficient Ir-catalyzed synthesis. Offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability for global buyers.
Patent CN111269075A details a cost-effective nickel-catalyzed route for 2,3-dihydroindanones, offering high regioselectivity and supply chain advantages for pharmaceutical manufacturing.
Novel reductive amination route for influenza inhibitor intermediate. High yield, safe scale-up, and cost-effective pharmaceutical manufacturing solutions.
Patent CN101863830A reveals a high-yield synthesis of 2-amino-5-bromoisonicotinic acid (>60%), offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN109134392A reveals a mild synthetic route for N2-alkenyl benzotriazoles. Achieve high selectivity and cost reduction in fine chemical manufacturing with scalable processes.
Patent CN113929587A reveals high-yield synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel sulfonation resolution method for dexmedetomidine intermediate ensures high yield and purity for pharmaceutical supply chains.
Novel one-step Lewis acid catalysis improves vinpocetin yield to 90% with >99% purity, offering significant supply chain stability and cost efficiency for global buyers.
Patent CN102718829B reveals high-yield TUDCA synthesis avoiding ion-exchange columns ensuring cost reduction and supply reliability for global pharmaceutical intermediates
Novel Pd-catalyzed oxidative coupling method for coumarin-pyrroles offers mild conditions and high atom economy for reliable pharmaceutical intermediate supply chains.
Patent CN102898357A details a high-yield Grignard route for Etoricoxib intermediates, offering superior impurity control and cost-effective pharmaceutical manufacturing solutions.
Novel patent CN114621103B details improved salbutamol sulfate synthesis offering high yield and simplified purification for global pharmaceutical supply chains.
Patent CN101456897B reveals a low-cost transfer hydrogenation route for 5-alpha reductase inhibitors, offering significant supply chain advantages.
Novel one-pot method for Pantoprazole Sodium reduces impurities and costs. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Novel one-step method using azlactones offers high yield and mild conditions for reliable dihydroquinolinone supplier operations.